A Northwestern University cardiologist who sparked a federal investigation into a fellow physician for alleged misconduct was fired after being denied tenure.
Dr. Nalini Rajamannan, who was an associate professor of medicine at the university, believes she was fired for providing evidence to federal investigators and for challenging the university’s star surgeon.
In 2008, Rajamannan accused cardiac surgeon Dr. Patrick McCarthy of implanting an experimental Myxo ring, invented by McCarthy and manufactured by Edwards Lifesciences Corp. (NYSE:EW), without obtaining informed consent from the patient.
“The device in question, originally known as the Myxo annuloplasty ring, has been at the center of an FDA investigation, a Senate inquiry, and a number of lawsuits against the annuloplasty ring’s inventor, Dr. Patrick McCarthy (Northwestern University, Chicago, IL), his hospital, and ring manufacturer Edwards Lifesciences," Heartwire reported.
Northwestern claims Rajamannan was terminated only because she was denied tenure, despite the fact that she had funding from the National Institutes of Health well into 2012. Rajamannan believes she was fired for providing federal investigators with evidence that one patient implanted with the device suffered a heart attack during surgery.
"Prior to the time I first brought this issue to the attention of my superiors at Northwestern, I was enjoying a successful career and anticipated making tenure and ending my career at that institution," Rajamannan told Heartwire."However, I didn’t know my career would end so quickly and end, no doubt, as a result of the revelations I made. Since I brought the issue of the implantation of the Myxo ring without informed consent to the attention of hospital officials, my career has taken an unexpected downward spiral."
Rajamannan has claimed that the university attempted to silence her when she first brought her concerns to chief of cardiology Dr. Robert Bonow.
"You don’t cross Pat McCarthy," Rajamannan claims she was told, "We’re going to separate you, so don’t pursue this."
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Invacare lays off 50 workers worldwide
Home health equipment maker Invacare (NYSE:IVC) is laying off about 50 workers worldwide, citing a difficult economy and declining reimbursements to its customers.
- James Reinstein resigns Cyberonics
Cyberonics senior Vice President and Chief Commercial officer James Rein resigned his position.
- SensiVidia loses a board member, gains two more
David Smith resigned from SensiVida’s board of directors. Montieth Estes and John Spoonhower were appointed in his stead.
- PPD’s CEO "sticking around" after sale
PPD’s CEO Ray Hill could come away with nearly $8 million for two and a half weeks of work after the company’s $3.9 billion sale to the Carlyle Group and Hellman & Friendman.
- Mitek Systems appoint Russell Clark as CFO
Mitek Systems Inc appointed Russell Clark as its Chief Financial Officer.
- Histogenics forms Scientific Advisory Board
Waltham, Mass.-based Histogenics Corp announced the formation of its own Scientific Advisory Board.
- AdvaMedDx announces its 2012-2013 board of directors
AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed), has announced its 2012-2013 board of directors.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.